Abstract
The cytoplasmic polyadenylation element binding proteins (CPEBs) associate with specific sequences in mRNA 3′ untranslated regions to promote translation. They do so by inducing cytoplasmic polyadenylation, which requires specialized poly(A) polymerases. Aberrant expression of these proteins correlates with certain types of cancer, indicating that cytoplasmic RNA 3′ end processing is important in the control of growth. Several CPEB-regulated mRNAs govern cell cycle progression, regulate senescence, establish cell polarity, and promote tumorigenesis and metastasis. In this Opinion article, we discuss the emerging evidence that indicates a key role for the CPEBs in cancer biology.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Groppo, R. & Richter, J. D. Translational control from head to tail. Curr. Opin. Cell Biol. 21, 444–451 (2009).
Sonenberg, N. & Hinnebusch, A. G. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 136, 731–745 (2009).
Dever, T. E. Gene-specific regulation by general translation factors. Cell 108, 545–556 (2002).
Ruggero, D. & Pandolfi, P. P. Does the ribosome translate cancer? Nature Rev. Cancer 3, 179–192 (2003).
Wendel, H. G. et al. Dissecting eIF4E action in tumorigenesis. Genes Dev. 21, 3232–3237 (2007).
Richter, J. D. & Sonenberg, N. Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nature 433, 477–480 (2005).
Sonenberg, N. Translation factors as effectors of cell growth and tumorigenesis. Curr. Opin. Cell Biol. 5, 955–960 (1993).
Lazaris-Karatzas, A. et al. Ras mediates translation initiation factor 4E-induced malignant transformation. Genes Dev. 6, 1631–1642 (1992).
Ruggero, D. et al. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nature Med. 10, 484–486 (2004).
Shamji, A. F., Nghiem, P. & Schreiber, S. L. Integration of growth factor and nutrient signaling. Mol. Cell 12, 271–280 (2003).
Guertin, D. A. & Sabatini, D. M. The Pharmacology of mTOR Inhibition. Sci. Signal. 2, pe24 (2009).
Hsieh, A. C. et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature 485, 55–61 (2012).
Hake, L. E. & Richter, J. D. CPEB is a specificity factor that mediates cytoplasmic polyadenylation during Xenopus oocyte maturation. Cell 79, 617–627 (1994).
Stebbins-Boaz, L. E. et al. CPEB controls the cytoplasmic polyadenylation of cyclin, Cdk2 and c-mos mRNAs and is necessary for oocyte maturation in Xenopus. EMBO J. 15, 2582–2592 (1996).
Liu, J. & Maller, J. L. Xenopus Polo-like kinase Plx1: a multifunctional mitotic kinase. Nature 24, 238–247 (2005).
Peng, A. & Maller, J. L. Serine/threonine phosphatases in the DNA damage response and cancer. Oncogene 29, 5977–5988 (2010).
Groisman, I., Jung, M. Y., Sarkissian, M., Cao, Q. & Richter, J. D. Translational control of the embryonic cell cycle. Cell 109, 473–483 (2002).
Groisman, I. et al. Control of cellular senescence by CPEB. Genes Dev. 20, 2701–2712 (2006).
Novoa, I., Gallego, J., Ferreira, P. G. & Mendez, R. Mitotic cell-cycle progression is regulated by CPEB1 and CPEB4-dependent translational control. Nature Cell Biol. 12, 447–456 (2010).
Di Giammartino, D. C., Nishida, K. & Manley, J. L. Mechanisms and consequences of alternative polyadenylation. Mol. Cell 43, 853–866 (2011).
Barnard, D. C., Ryan, K., Manley, J. L. & Richter, J. D. Symplekin and xGLD-2 are required for CPEB-mediated cytoplasmic polyadenylation. Cell 119, 641–651 (2004).
Cao, Q., Kim, J. H. & Richter, J. D. CDK1 and calcineurin regulate Maskin association with eIF4E and translational control of cell cycle progression. Nature Struct. Mol. Biol. 13, 1128–1134 (2006).
Sarkissian, M. et al. Progesterone and insulin stimulation of CPEB-dependent polyadenylation is regulated by Aurora A and glycogen synthase kinase-3. Genes Dev. 18, 48–61 (2004).
Mendez, R. et al. Phosphorylation of CPE binding factor by Eg2 regulates translation of c-mos mRNA. Nature 404, 302–307 (2000).
Kim, J. H. & Richter, J. D. Opposing polymerase-deadenylase activities regulate cytoplasmic polyadenylation. Mol. Cell 24, 173–183 (2006).
Kim, J. H. & Richter, J. D. RINGO/cdk1 and CPEB mediate poly(A) tail stabilization and translational regulation by ePAB. Genes Dev. 21, 2571–2579 (2007).
Minshall, N. et al. CPEB interacts with an ovary-specific eIF4E and 4E-T in early Xenopus oocytes. J. Biol. Chem. 282, 37389–37401 (2007).
Jung, M. Y., Lorenz, L. & Richter, J. D. Translational control by neuroguidin, a eukaryotic initiation factor 4E and CPEB binding protein. Mol. Cell. Biol. 26, 4277–4287 (2006).
Mendez, R. et al. Phosphorylation of CPEB by Eg2 mediates the recruitment of CPSF into an active cytoplasmic polyadenylation complex. Mol. Cell 6, 1253–1259 (2000).
Colgan, D. F. & Manley, J. L. Mechanism and regulation of mRNA polyadenylation. Genes Dev. 11, 2755–2766 (1997).
McGrew, L. L. & Richter, J. D. Translational control by cytoplasmic polyadenylation during Xenopus oocyte maturation: characterization of cis and trans elements and regulation by cyclin/MPF. EMBO J. 9, 3743–3751 (1990).
McGrew, L. L. et al. Poly(A) elongation during Xenopus oocyte maturation is required for translational recruitment and is mediated by a short sequence element. Genes Dev. 3, 803–815 (1989).
Fox, C. A. et al. Poly(A) addition during maturation of frog oocytes: distinct nuclear and cytoplasmic activities and regulation by the sequence UUUUUAU. Genes Dev. 3, 2151–2162 (1989).
Kuge, H. & Richter, J. D. Cytoplasmic 3′ poly(A) addition induces 5′ cap ribose methylation: implications for translational control of maternal mRNA. EMBO J. 14, 6301–6310 (1995).
Kuge, H. et al. Cap ribose methylation of c-mos mRNA stimulates translation and oocyte maturation in Xenopus laevis. Nucleic Acids Res. 26, 3208–3214 (1998).
Lantz, V. et al. The Drosophila orb gene is predicted to encode sex-specific germline RNA-binding proteins and has localized transcripts in ovaries and early embryos. Development 115, 75–88 (1992).
Lantz, V. et al. The Drosophila orb RNA-binding protein is required for the formation of the egg chamber and establishment of polarity. Genes Dev. 8, 598–613 (1994).
Christerson, L. B. & McKearin, D. M. orb is required for anteroposterior and dorsoventral patterning during Drosophila oogenesis. Genes Dev. 8, 614–628 (1994).
Zhang, J. H. et al. Cytoplasmic polyadenylation element binding protein is a conserved target of tumor suppressor HRPT2/CDC73. Cell Death Differ. 17, 1551–15565 (2010).
Wang, L. et al. A regulatory cytoplasmic poly(A) polymerase in Caenorhabditis elegans. Nature 419, 312–316 (2002).
Read, R. L. et al. Cytoplasmic poly(A) polymerases mediate cellular responses to S phase arrest. Proc. Natal. Acad. Sci. USA 99, 12079–12084 (2002).
Saitoh, S. et al. Cid13 is a cytoplasmic poly(A) polymerase that regulates ribonucleotide reductase mRNA. Cell 109, 563–573 (2002).
Kadyk, L. C. & Kimble, J. Genetic regulation of entry into meiosis in Caenorhabditis elegans. Development 125, 1803–1813 (1998).
Tay, J., Hodgman, R. & Richter, J. D. The Control of cyclin B1 mRNA translation during mouse oocyte maturation. Dev. Biol. 221, 1–9 (2000).
Tay, J. et al. Regulated CPEB phosphorylation during meiotic progression suggests a mechanism for temporal control of maternal mRNA translation. Genes Dev. 17, 1457–1462 (2003).
Burns, D. M. & Richter, J. D. CPEB regulation of human cellular senescence, energy metabolism, and p53 mRNA translation. Genes Dev. 22, 3449–3460 (2008).
Udagawa, T. et al. Bidirectional control of mRNA translation and synaptic plasticity by the cytoplasmic polyadenylation complex. Mol. Cell 47, 253–266 (2012).
Burns, D. M., D'Ambrogio, A., Nottrott, S. & Richter, J. D. CPEB and two poly(A) polymerases control miR-122 stability and p53 mRNA translation. Nature 473, 105–108 (2011).
Mendez, R. & Richter, J. D. Translational control by CPEB: a means to the end. Nature Rev. Mol. Cell. Biol. 2, 521–529 (2001).
Huang, Y. S., Kan, M. C., Lin, C. L. & Richter, J. D. CPEB3 and CPEB4 in neurons: analysis of RNA-binding specificity and translational control of AMPA receptor GluR2 mRNA. EMBO J. 25, 4865–4876 (2006).
Igea, A. et al. Meiosis requires a translational positive loop where CPEB1 ensues its replacement by CPEB4. EMBO J. 29, 2182–2193 (2010).
Chen, P. J. & Huang, Y. S. CPEB2–eEF2 interaction impedes HIF-1α RNA translation. EMBO J. 31, 959–971 (2011).
Hosoda, N. et al. Anti-proliferative protein Tob negatively regulates CPEB3 target by recruiting Caf1 deadenylase. EMBO J. 30, 1311–1323 (2011).
Pavlopoulos, E. et al. Neuralized1 activates CPEB3: a function for nonproteolytic ubiquitin in synaptic plasticity and memory storage. Cell 147, 1369–1383 (2011).
Ortiz-Zapater, E. et al. Key contribution of CPEB4-mediated translational control to cancer progression. Nature Med. 18, 83–90 (2011).
Groppo, R. & Richter, J. D. CPEB control of NF- B nuclear localization and interleukin-6 production mediates cellular senescence. Mol. Cell. Biol. 31, 2707–2714 (2011).
Rhodes, D. R. et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9, 166–180 (2007).
Tay, J. & Richter, J. D. Germ cell differentiation and synaptonemal complex formation are disrupted in CPEB knockout mice. Dev. Cell 1, 201–213 (2001).
Wu, L. et al. CPEB-mediated cytoplasmic polyadenylation and the regulation of experience-dependent translation of α-CaMKII mRNA at synapses. Neuron 21, 1129–1139 (1998).
Silvera, D., Formenti, S. C. & Schneider, R. J. Translational control in cancer. Nature Rev. Cancer 10, 254–266 (2010).
Katoh, T. et al. Selective stabilization of mammalian microRNAs by 3′ adenylation mediated by the cytoplasmic poly(A) polymerase GLD-2. Genes Dev. 23, 433–438 (2009).
D'Ambrogio, A. et al. Specific miRNA stabilization by Gld2-catalyzed monoadenylation. Cell Rep. 2, 1537–1345 (2012).
Thomson, J. M. et al. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev. 20, 2202–2207 (2006).
Piqué, M., López, J. M., Foissac, S., Guigó, R. & Mendez, R. A. Combinatorial code for CPE-mediated translational control. Cell 132, 434–448 (2008).
Belloc, E. & Méndez, R. A deadenylation negative feedback mechanism governs meiotic metaphase arrest. Nature 452, 1017–1021 (2008).
Hayflick, L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37, 614–636 (1965).
Evan, G. I. & d'Adda di Fagagna, F. Cellular senescence: hot or what? Mol. Cell 19, 25–31 (2009).
Collado, M., Blasco, M. A. & Serrano, M. Cellular senescence in cancer and aging. Cell 130, 223–233 (2007).
Cairns, R. A., Harris, I. S. & Mak, T. W. Regulation of cancer cell metabolism. Nature Rev. Cancer 11, 85–95 (2011).
Chen, M., David, C. J. & Manley, J. L. Concentration-dependent control of pyruvate kinase M mutually exclusive splicing by hnRNP proteins. Nature Struct. Mol. Biol. 19, 346–354 (2012).
Christofk, H. R. et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452, 230–233 (2008).
Lin, C. L., Evans, V., Shen, S., Xing, Y. & Richter, J. D. The nuclear experience of CPEB: implications for RNA processing and translational control. RNA 16, 338–348 (2010).
Kuilman, T. et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133, 1019–1031 (2008).
Braig, M. et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436, 660–665 (2005).
Prieur, A. & Peeper, D. S. Cellular senescence in vivo: a barrier to tumorigenesis. Curr. Opin. Cell Biol. 20, 150–155 (2008).
Michaloglou, C. et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436, 720–724 (2005).
Chen, Z. et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436, 725–730 (2005).
Jing, H. et al. Opposing roles of NF- B in anti-cancer treatment outcome unveiled by cross-species investigations. Genes Dev. 25, 2137–2146 (2011).
Nagaoka, K., Udagawa, T. & Richter, J. D. CPEB-mediated ZO-1 mRNA localization is required for epithelial tight-junction assembly and cell polarity. Nature Commun. 3, 675 (2012).
Kalluri, R. & Weinberg, R. A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420–1428 (2009).
McCaffrey, L. M., Montalbano, J., Mihai, C. & Macara, I. G. Loss of the Par3 polarity protein promotes breast tumorigenesis and metastasis. Cancer Cell 22, 601–614 (2012).
Sullivan, N. J. et al. Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells. Oncogene 28, 2940–2947 (2009).
Nairismägi, M. L. et al. Translational control of TWIST1 expression in MCF-10A cell lines recapitulating breast cancer progression. Oncogene 31, 4960–4966 (2012).
Huang, Y. S. Facilitation of dendritic mRNA transport by CPEB. Genes Dev. 17, 638–653 (2003).
Wang, H. et al. Dexamethasone as a chemosensitizer for breast cancer chemotherapy: potentiation of the antitumor activity of adriamycin, modulation of cytokine expression, and pharmacokinetics. Int. J. Oncol. 30, 947–953 (2007).
McClellan, M. et al. An accelerated pathway for targeted cancer therapies. Nature Rev. Drug Discov. 10, 79–80 (2011).
Ule, J. CLIP identifies Nova-regulated RNA networks in the brain. Science 302, 1212–1215 (2003).
König, J., Zarnack, K., Luscombe, N. M. & Ule, J. Protein–RNA interactions: new genomic technologies and perspectives. Nature Rev. Genet. 13, 77–83 (2012).
Ingolia, N. T., Brar, G. A., Rouskin, S., McGeachy, A. M. & Weissman, J. S. The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragments. Nature Protoc. 7, 1534–1550 (2012).
Du, L. & Richter, J. D. Activity-dependent polyadenylation in neurons. RNA 11, 1340–1347 (2005).
Beilharz, T. H. & Preiss, T. Polyadenylation state microarray (PASTA) analysis. Methods Mol. Biol. 759, 133–148 (2011).
Page, R. D. M. in Current Protocols in Bioinformatics (John Wiley & Sons, Inc., USA).
Acknowledgements
The authors thank O. Rando for help with the bioinformatic analysis. K.N. was supported by JSPS postdoctoral fellowships for Research Abroad. Work in the authors' laboratory was supported by grants from the US National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
Supplementary information
Supplementary information S1 (table)
Meta-analysis in Figure 2 (PDF 203 kb)
Glossary
- Cytoplasmic polyadenylation element binding protein
-
(CPEB). All CPEB proteins contain two RNA recognition motifs and two zinc fingers. CPEB1 binds to the cytoplasmic polyadenylation element, a U-rich structure in mRNA 3′ untranslated regions and recruits a complex of proteins that mediate polyadenylation and translation. CPEB24 may also bind U-rich structures, but probably with different affinities from those of CPEB1.
- Eukaryotic translation initiation factor 4F
-
(eIF4F). A protein complex composed of eIF4A, eIF4E and eIF4G. eIF4A is an RNA helicase, eIF4E binds the cap, and eIF4G, through interaction with the multisubunit initiation factor eIF3, recruits the 40S ribosomal subunit to the 5′ end of the mRNA.
- Germline development 2
-
(GLD2). A non-canonical poly(A) polymerase that associates with CPEB1 to polyadenylate mRNAs in the cytoplasm. Independently from CPEBs, GLD2 also 3′ monoadenylates and stabilizes specific miRNAs.
- GLD4
-
A paralogue of GLD2. In human fibroblasts, it associates with CPEB1 to polyadenylate TP53 mRNA.
- m7GpppG
-
Also known as the cap. The structure found at the 5′ end of all nuclear-encoded eukaryotic mRNAs. It consists of a 7-methyl-guanine nucleotide connected to the mRNA via an unusual 5′ to 5′ linkage. The cap ensures mRNA stability and is essential for translation except for those messengers that use an internal ribosome entry site.
- Senescence
-
A phenomenon by which primary cells exit the cell cycle and undergo several biochemical and morphological changes. Senescence can be induced by oncogenes, changes in substrate adhesion, alterations in oxygen tension and many other parameters; it is a mechanism of tumour suppression.
Rights and permissions
About this article
Cite this article
D'Ambrogio, A., Nagaoka, K. & Richter, J. Translational control of cell growth and malignancy by the CPEBs. Nat Rev Cancer 13, 283–290 (2013). https://doi.org/10.1038/nrc3485
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrc3485
This article is cited by
-
TOB1 and TOB2 mark distinct RNA processing granules in differentiating lens fiber cells
Journal of Molecular Histology (2024)
-
CPEB2 inhibit cell proliferation through upregulating p21 mRNA stability in glioma
Scientific Reports (2023)
-
Longitudinal analysis of individual cfDNA methylome patterns in metastatic prostate cancer
Clinical Epigenetics (2021)
-
The regulation of protein translation and its implications for cancer
Signal Transduction and Targeted Therapy (2021)
-
Upregulation of circ_0000199 in circulating exosomes is associated with survival outcome in OSCC
Scientific Reports (2020)